Blog Posts by Cathy Craft, RAC

Form Follows Function
OIR Reorganizes to Meet the Advancing Wave of Molecular Diagnostics
Monday, May 05, 2014
Evolution of an Assay
Could this also be a revolution in FDA thinking?
Thursday, June 06, 2013
TDM Assays
The net under the safe and effective tightrope
Friday, May 17, 2013
Lipid Profiling
The tests that made HDL and LDL household acronyms
Wednesday, May 08, 2013
Not Just Another Biomarker Meeting?
The IOM takes on co-development
Friday, March 01, 2013
Keeping RA/QA Staffs Current
Accepting regulatory change starts with staying current
Tuesday, February 12, 2013

Recent Blogs

The Staple That Changed an Industry LDT regulation and the perils of challenging Eminem to a rap battle
FDA Releases the Kraken Whichever way this breaks, it's long past time to have this conversation in a meaningful way
Illumina Acquires Myraqa Acquisition Strengthens Illumina’s Clinical Readiness
The Spirit of GLP A Best Practice for IVDs
Process Performance Qualification (PPQ) Lots So, how many lots are required?
The Case for Risk-based Monitoring Better the devil you know...
Form Follows Function OIR Reorganizes to Meet the Advancing Wave of Molecular Diagnostics
CDRH Unveils New PMA Guidance Documents Attention shoppers, it's two-for-one day!